Tuesday, December 2, 2008 - 8:46AM EST

Review Articles

41. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Author
Wilt TJ; Niewoehner D; MacDonald R; Kane RL; Wilt TJ; Niewoehner D; MacDonald R; Kane RL; Wilt TJ; Niewoehner D; MacDonald R; Kane RL;
Institution
Minnesota Agency for Healthcare Research and Quality Evidence-based Practice Center, Minneapolis Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota 55417, USA. tim.wilt@med.va.gov
Journal
Ann Intern Med. 2007 Nov 6;147(9):639-53.
Abstract URL
Click here to view abstract

42. Psychiatric considerations in pulmonary disease.

Author
Shanmugam G; Bhutani S; Khan DA; Brown ES; Shanmugam G; Bhutani S; Khan DA; Brown ES; Shanmugam G; Bhutani S; Khan DA; Brown ES;
Institution
Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8849, USA.
Journal
Psychiatr Clin North Am. 2007 Dec;30(4):761-80.
Abstract URL
Click here to view abstract

43. Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation.

Author
Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A; Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A; Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A;
Institution
Ranbaxy Laboratories Ltd, Department of Pharmacology, New Drug Discovery Research (R & D III), Plot No. 20, Sector-18, Gurgaon-122 001, India. Lalitha.vijayakrishnan@ranbaxy.com
Journal
Expert Opin Investig Drugs. 2007 Oct;16(10):1585-99.
Abstract URL
Click here to view abstract

44. Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease.

Author
Austin M; Wood-Baker R;
Institution
University of Tasmania, 656 Sandy Bay Road, Sandy Bay, Tasmania, Australia 7005. maaustin@utas.edu.au
Journal
Cochrane Database Syst Rev. 2006 Jul 19;3:CD005534.
Abstract URL
Click here to view abstract

45. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes.

Author
Gartlehner G; Hansen RA; Carson SS; Lohr KN;
Institution
Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. gartlehner@schsr.unc.edu
Journal
Ann Fam Med. 2006 May-Jun;4(3):253-62.
Abstract URL
Click here to view abstract

46. ABC of chronic obstructive pulmonary disease. Diagnosis.

Author
Currie GP; Legge JS;
Institution
Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal
BMJ. 2006 May 27;332(7552):1261-3.

47. Roflumilast for the treatment of chronic obstructive pulmonary disease.

Author
Antoniu SA;
Institution
Clinic of Pulmonary Disease, 30 Dr I Cihac Street, 700115 Iasi, Romania. sabinaantoniu@excite.com
Journal
Curr Opin Investig Drugs. 2006 May;7(5):412-7.
Abstract URL
Click here to view abstract

48. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors.

Author
Devereux G;
Institution
Department of Environmental and Occupational Medicine, University of Aberdeen, Aberdeen.
Journal
BMJ. 2006 May 13;332(7550):1142-4.

49. Update in chronic obstructive pulmonary disease 2005.

Author
Fabbri LM; Luppi F; Beghe B; Rabe KF;
Institution
Department of Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. fabbri.leonardo@unimo.it
Journal
Am J Respir Crit Care Med. 2006 May 15;173(10):1056-65.

50. Effective management of COPD in primary care - the role of long-acting beta agonist/inhaled corticosteroid combination therapy.

Author
van Schayck CP; Reid J;
Institution
Department of General Practice, University of Maastricht Research Institute CAPHRI, P.O. Box 616, 6200 MD Maastricht, The Netherlands. onno.vanschayck@hag.unimaas.nl
Journal
Prim Care Respir J. 2006 Jun;15(3):143-51. Epub 2006 Apr 11.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9